The coronavirus behind COVID-19 is dangerous because it combines several traits that rarely appear together in a single pathogen: it spreads easily before symptoms appear, it attacks blood vessels and organs throughout the body, and it triggers an immune overreaction that can be more destructive than the virus itself. No single feature makes it uniquely lethal. It’s the combination that sets it apart.
How the Virus Gets Into Your Cells
SARS-CoV-2 enters the body by latching onto a protein called ACE2, which sits on the surface of many human cells. The virus’s spike protein fits onto ACE2 like a key in a lock, connecting at three specific hotspots through an extensive network of chemical bonds across a large contact surface. This isn’t a loose attachment. Seventeen residues on the spike protein interlock with twenty on the ACE2 receptor, creating a strong, stable grip that allows the virus to fuse with the cell membrane and slip inside.
The problem is where ACE2 receptors are found. They’re abundant in the lungs, but also in the heart, kidneys, intestines, esophagus, bladder, and the lining of blood vessels. This wide distribution is why COVID-19 was never just a respiratory illness. Every organ with ACE2 receptors is a potential target for direct viral invasion.
It Spreads Before People Feel Sick
One of the most consequential features of SARS-CoV-2 is that people carry high levels of the virus before they develop symptoms, or even if they never develop symptoms at all. Studies have shown that asymptomatic and symptomatic individuals carry comparable amounts of virus, meaning someone who feels perfectly fine can be just as contagious as someone who’s visibly ill. A mass screening study in Luxembourg confirmed that asymptomatic carriers infect roughly the same number of people as symptomatic ones.
This invisible spread proved devastating in real-world settings. In one US care home outbreak, a single positive case led to 63% of residents becoming infected. Half of those infections were asymptomatic and would never have been detected without routine testing. Researchers described asymptomatic transmission as the “Achilles’ heel” of infection control.
The original strain of SARS-CoV-2 had an average reproduction number (R0) of about 2.5, meaning each infected person spread the virus to roughly two or three others. That’s higher than the 2009 H1N1 flu pandemic (R0 of 1.7) and the 1918 flu pandemic (R0 of 2.0). Later variants like Delta and Omicron were even more transmissible. The incubation period also shortened over time: the original strain averaged about 4.6 days from exposure to symptoms, while Omicron averaged 3.6 days, giving people less time to realize they’d been exposed.
The Immune System Turns on the Body
In many severe cases, the greatest damage comes not from the virus directly but from the body’s own immune response spiraling out of control. When SARS-CoV-2 infects cells, it can trigger a form of inflammatory cell death called pyroptosis, which dumps large quantities of signaling molecules into surrounding tissue. These signals recruit more immune cells, which release still more inflammatory molecules, creating a feedback loop.
In some patients, this escalates into what’s known as a cytokine storm: an unrestrained flood of inflammatory proteins including IL-6, IL-1, TNF-alpha, and interferon-gamma. These chemicals, normally useful in small amounts for fighting infection, become destructive at high concentrations. They damage healthy tissue, cause fluid to leak into the lungs, and can push the body toward organ failure. Patients heading toward this kind of crisis typically show very high levels of inflammatory markers in their blood, including ferritin.
Several factors set the stage for this overreaction. Genetic differences in immune function, the virus’s ability to suppress early antiviral signals called interferons, and excessive activity from a type of immune defense involving structures called neutrophil extracellular traps all contribute. When the initial immune response is too slow to contain the virus, the delayed, compensatory surge tends to overshoot.
Damage Beyond the Lungs
Because ACE2 receptors line blood vessels throughout the body, and because those blood vessels are highly vascularized in organs like the lungs and kidneys, SARS-CoV-2 causes significant damage to the endothelium, the thin layer of cells forming the inner wall of every blood vessel. These cells normally regulate blood flow, control clotting, and manage immune responses. When the virus infects and damages them, that careful regulation breaks down.
The consequences are widespread. Damaged blood vessel walls trigger abnormal clotting, leading to blood clots in the lungs, legs, brain, and other organs. The virus also structurally modifies ACE2 in ways that strip it of its normal protective function for the heart and cardiovascular system. Lab studies showed active viral replication inside blood vessel tissue, with viral levels increasing for days after initial infection.
The systemic cytokine storm compounds this vascular damage, pushing inflammation into organs far from the lungs. In the heart, this leads to acute coronary events, myocardial injury, and heart failure. In the kidneys, it causes acute kidney injury and, in severe cases, lasting fibrosis. In the brain, the inflammatory surge compromises the blood-brain barrier, allowing inflammatory molecules to cross into neural tissue and cause neuroinflammation, which may explain the cognitive symptoms many patients report.
Age and Risk Are Not Equal
COVID-19’s danger varies enormously depending on who is infected. Using data from the pre-vaccine period, researchers estimated that the infection fatality rate at age 80 was roughly 8.4%, while at age 5 it was 0.001%. That makes the virus more than 8,000 times deadlier for an 80-year-old than for a young child. The lowest risk falls among children aged 5 to 9, with mortality risk following a J-shaped curve that climbs steeply after middle age.
Population-level fatality rates also depend heavily on a country’s age structure. Estimates from the pre-vaccine era put the overall infection fatality rate between 0.14% and 0.42% in low-income countries (which tend to have younger populations) and between 0.78% and 1.79% in high-income countries with older populations. This helps explain why the pandemic’s toll looked so different across regions even before vaccines were available.
How Vaccination Changed the Math
Vaccines dramatically reduced the risk of severe disease. Full vaccination was 94% effective at preventing hospitalization among adults 65 and older. In England, the hospitalization rate for fully vaccinated people over 80 was 50.5 per 100,000, compared to 143.9 per 100,000 for unvaccinated individuals. Mortality rates showed an even starker gap: 45.5 versus 145.4 per 100,000.
Among hospitalized patients, the difference in outcomes was striking. One study found an in-hospital mortality rate of 3% for vaccinated patients compared to 25.3% for unvaccinated ones. Another reported rates of 1.53% versus 11.17%. The need for mechanical ventilation also dropped sharply: 4 to 4.7% of fully vaccinated patients required it, compared to 16 to 18% of those without vaccination or with only partial vaccination. Complete vaccination was associated with roughly a 70% reduction in mortality among hospitalized patients.
Long COVID and Lasting Damage
The virus’s danger doesn’t end when the acute infection clears. Long COVID, defined as symptoms persisting more than three months after infection that can’t be explained by another diagnosis, affects a substantial portion of survivors. Conservative estimates place the prevalence at around 10% of all infections, which translates to more than 65 million people worldwide. Among those who were hospitalized, the rates are far higher: 50 to 70%.
A meta-analysis covering more than 1.28 million survivors found that 49% had at least one lingering symptom within 12 months of infection. The CDC estimates that roughly one in five adults aged 18 to 64 and one in four adults 65 and older experience persistent symptoms. Vaccination offers some protection here too, reducing long COVID rates to around 10 to 12%. The Omicron variant also appears to carry a lower long COVID risk (about 4.5%) compared to Delta (10.8%), though estimates vary by study and definition used.
The combination of direct organ invasion through ACE2, vascular damage from endothelial infection, and sustained immune dysregulation helps explain why so many body systems can remain disrupted long after the virus itself is gone. COVID-19 is dangerous not because it does one thing exceptionally well, but because it does many harmful things simultaneously, across nearly every organ system in the body.